80 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
51 | 23041051 | The kinase RSK2 modulates the sensitivity of ovarian cancer cells to cisplatin. | 2013 Jan | 1 |
52 | 23042098 | MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cells. | 2013 Jan | 12 |
53 | 23338561 | Antitumor properties of salinomycin on cisplatin-resistant human ovarian cancer cells in vitro and in vivo: involvement of p38 MAPK activation. | 2013 Apr | 1 |
54 | 23783141 | Activation of ERK1/2 and Akt is associated with cisplatin resistance in human lung cancer cells. | 2013 Jun | 7 |
55 | 24335178 | Potential molecular mechanisms for improved prognosis and outcome with neoadjuvant chemotherapy prior to laparoscopical radical hysterectomy for patients with cervical cancer. | 2013 | 1 |
56 | 22179790 | RNAi-mediated knockdown of ERK1/2 inhibits cell proliferation and invasion and increases chemosensitivity to cisplatin in human osteosarcoma U2-OS cells in vitro. | 2012 Apr | 2 |
57 | 21130731 | Acquisition of chemoresistance in intrahepatic cholangiocarcinoma cells by activation of AKT and extracellular signal-regulated kinase (ERK)1/2. | 2011 Feb 18 | 2 |
58 | 21444628 | Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells. | 2011 Jul | 5 |
59 | 21687949 | Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways. | 2011 Sep-Oct | 1 |
60 | 19962780 | Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2. | 2010 Aug | 5 |
61 | 18661133 | Characterization of kinase suppressor of Ras-1 expression and anticancer drug sensitivity in human cancer cell lines. | 2009 Apr | 1 |
62 | 19428505 | Role of MAPKs in platinum-induced neuronal apoptosis. | 2009 Mar | 1 |
63 | 17942395 | Epidermal growth factor receptor pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells. | 2008 Jan 11 | 3 |
64 | 18093981 | A sensitive flow cytometry-based nucleotide excision repair assay unexpectedly reveals that mitogen-activated protein kinase signaling does not regulate the removal of UV-induced DNA damage in human cells. | 2008 Feb 29 | 1 |
65 | 18332870 | Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine signaling. | 2008 Jun 26 | 2 |
66 | 18425342 | Constitutive activation of p70 S6 kinase is associated with intrinsic resistance to cisplatin. | 2008 May | 3 |
67 | 18544565 | Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells. | 2008 Jul | 3 |
68 | 17023032 | A high nuclear basal level of ERK2 phosphorylation contributes to the resistance of cisplatin-resistant human ovarian cancer cells. | 2007 Feb | 1 |
69 | 17125914 | Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance. | 2007 Jun 18 | 2 |
70 | 17508026 | ERK1/2 is highly phosphorylated in melanoma metastases and protects melanoma cells from cisplatin-mediated apoptosis. | 2007 Sep | 1 |
71 | 17513610 | Expression of human glutathione S-transferase P1 mediates the chemosensitivity of osteosarcoma cells. | 2007 May | 2 |
72 | 17982682 | Erythropoietin reduces cisplatin-induced neurotoxicity without impairment of cytotoxic effects against tumor cells. | 2007 Dec | 2 |
73 | 16395709 | p38 MAPK turns hepatocyte growth factor to a death signal that commits ovarian cancer cells to chemotherapy-induced apoptosis. | 2006 Jun 15 | 2 |
74 | 16723633 | Polynuclear platinum anticancer drugs are more potent than cisplatin and induce cell cycle arrest in glioma. | 2006 Jul | 1 |
75 | 15843040 | Pharmacological inhibitors of extracellular signal-regulated protein kinases attenuate the apoptotic action of cisplatin in human myeloid leukemia cells via glutathione-independent reduction in intracellular drug accumulation. | 2005 Apr 15 | 3 |
76 | 16039614 | Activation of ERK during DNA damage-induced apoptosis involves protein kinase Cdelta. | 2005 Sep 9 | 2 |
77 | 15250250 | Role of ERK1/2 kinase in cisplatin-induced apoptosis in human ovarian carcinoma cells. | 2004 Jun | 2 |
78 | 12439598 | Ras-mediated activation of ERK by cisplatin induces cell death independently of p53 in osteosarcoma and neuroblastoma cell lines. | 2002 Nov | 1 |
79 | 11170260 | Cisplatin-induced response of c-jun N-terminal kinase 1 and extracellular signal--regulated protein kinases 1 and 2 in a series of cisplatin-resistant ovarian carcinoma cell lines. | 2000 Dec | 19 |
80 | 10353733 | Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. | 1999 May | 11 |